79
Participants
Start Date
November 12, 2018
Primary Completion Date
July 20, 2020
Study Completion Date
July 20, 2020
GRF6021
GRF6021 for IV infusion
Placebo
Placebo for IV infusion
Alfred Hospital, Melbourne
Hopital de la Timone, Marseille
Wake Research, Raleigh
CHU Caremeau, Nîmes
Atlanta Center for Medical Research, Atlanta
NeuroTrials Research Inc., Atlanta
CHU Purpan - Hopital Pierre Paul Riquet, Toulouse
Riverside Clinical Research, Edgewater
MD Clinical, Hallandale
Research Centers of America, LLC, Hollywood
Suncoast Research Group, LLC, Miami
Qps_Mra, Llc, South Miami
Moonshine Research Center, Doral
CHU Grenoble Alpes, Grenoble
Cleveland Clinic, Cleveland
SRI Biosciences, Plymouth
Quest Research Institute, Farmington Hills
Hopital Roger Salengro, Lille
PsychCare Consultants Research, St Louis
Hopital Neurologique, Bron
Clinical Trials, Inc., Little Rock
UT Southwestern Medical Center, Dallas
CHU Charles Nicolle, Rouen
Centex Studies, INC., Houston
Rocky Mountain Movement Disorders Center, Englewood
CHU de Poitiers, Poitiers
Hopital Henri Mondor, Créteil
Oregon Health & Science University, Portland
Northwest Clinical Research Center, Bellevue
Lead Sponsor
Michael J. Fox Foundation for Parkinson's Research
OTHER
Alkahest, Inc.
INDUSTRY